These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18955711)
1. Immunological insulin resistance due to insulin antibodies developed after cessation of insulin therapy in a patient with type 2 diabetes. Hirano M; Arima H; Oiso Y Diabetes Care; 2008 Nov; 31(11):e84. PubMed ID: 18955711 [No Abstract] [Full Text] [Related]
2. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report. Hirai H; Ogata E; Kikuchi N; Kohno T; Machii N; Hasegawa K; Watanabe T; Satoh H J Med Case Rep; 2016 Jul; 10():202. PubMed ID: 27456688 [TBL] [Abstract][Full Text] [Related]
3. Insulin-induced skin complication in an anti-insulin antibody positive patient with type 2 diabetes. Hamasaki H; Hamasaki Y Diabetes Metab Syndr; 2018 Sep; 12(5):829-830. PubMed ID: 29661603 [No Abstract] [Full Text] [Related]
4. Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy. Greenfield JR; Tuthill A; Soos MA; Semple RK; Halsall DJ; Chaudhry A; O'Rahilly S Diabet Med; 2009 Jan; 26(1):79-82. PubMed ID: 19125765 [TBL] [Abstract][Full Text] [Related]
5. Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes. Hattori N; Duhita MR; Mukai A; Matsueda M; Shimatsu A Clin Chim Acta; 2014 Jun; 433():135-8. PubMed ID: 24642342 [TBL] [Abstract][Full Text] [Related]
6. Severe insulin resistance due to insulin antibodies. Xiao Y; Li X; Chao C; Huang G; Tang W; Liu S; Xie Z; Zhou Z J Diabetes; 2018 Jul; 10(7):611-613. PubMed ID: 29493088 [No Abstract] [Full Text] [Related]
7. Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance. Asai M; Kodera T; Ishizeki K; Uebori S; Kashiwaya T; Itoh H; Makino I Diabetes Res Clin Pract; 2003 Aug; 61(2):89-92. PubMed ID: 12951276 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of human monocomponent insulin with beef and pork monocomponent insulin in the treatment of a diabetic with insulin resistance]. Wu W; Nolte M; Karam J Zhonghua Nei Ke Za Zhi; 1987 Nov; 26(11):644-5, 677. PubMed ID: 3327662 [No Abstract] [Full Text] [Related]
9. Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA). Maneschi F; Fineberg SE; Kohner EM Diabetes Care; 1982; 5 Suppl 2():175-9. PubMed ID: 6765532 [TBL] [Abstract][Full Text] [Related]
10. [A 75-year-old type 2 diabetes mellitus case responding strikingly troglitazone: possible mechanism of insulin resistance induced by insulin antibody]. Takahashi S; Oida K; Miyamori I Nihon Ronen Igakkai Zasshi; 2000 Apr; 37(4):344-8. PubMed ID: 10917034 [TBL] [Abstract][Full Text] [Related]
11. [Immunologic response to insulin therapy]. Saccarello A; De Micheli A; Boeri D; Maiello M Clin Ter; 1982 Aug; 102(3):293-308. PubMed ID: 6183045 [No Abstract] [Full Text] [Related]
12. Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin molecules. Jaeger C; Winter S; Eckhard M; Hardt P; Brendel MD; Bretzel RG Acta Diabetol; 2008 Sep; 45(3):191-4. PubMed ID: 18493700 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of biosynthetic human insulin. Humoral immune response in diabetic patients beginning insulin treatment and in patients previously treated with other insulins. Di Mario U; Arduini P; Tiberti C; Lombardi G; Pietravalle P; Andreani D Diabetes Res Clin Pract; 1986; 2(6):317-24. PubMed ID: 3545723 [TBL] [Abstract][Full Text] [Related]
14. [Insulin and immunology--a correlation]. Federlin K; Velcóvsky HG; Becker F; Discher T; Hammes HP; Marhoffer W Z Gesamte Inn Med; 1990 Oct; 45(20):601-4. PubMed ID: 2099577 [TBL] [Abstract][Full Text] [Related]
15. [Insulin resistance due to antibody in type I diabetes]. Enríquez Acosta L Rev Clin Esp; 1984 Jan; 172(1):57-8. PubMed ID: 6369446 [No Abstract] [Full Text] [Related]
16. Resistance and allergy to recombinant human insulin. Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus. Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740 [No Abstract] [Full Text] [Related]
18. Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes. Schlüter KJ; Kerp L Diabetes Care; 1982; 5 Suppl 2():152-60. PubMed ID: 6765528 [TBL] [Abstract][Full Text] [Related]
19. New forms of insulin and their use in the treatment of diabetes. Yue DK; Turtle JR Diabetes; 1977 Apr; 26(4):341-5. PubMed ID: 66165 [No Abstract] [Full Text] [Related]
20. U-500 insulin in the treatment of antibody-mediated insulin resistance. Nathan DM; Axelrod L; Flier JS; Carr DB Ann Intern Med; 1981 May; 94(5):653-6. PubMed ID: 7015948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]